Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) shot up 0.1% during mid-day trading on Tuesday . The stock traded as high as $2.83 and last traded at $2.8230. 2,659 shares changed hands during trading, a decline of 77% from the average session volume of 11,653 shares. The stock had previously closed at $2.8202.
Medexus Pharmaceuticals Trading Down 1.5%
The firm has a fifty day simple moving average of $2.76 and a 200-day simple moving average of $2.31.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Recommended Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
